Since MM is a heterogeneous disease with different patterns of clonal evolution [60], to better evaluate SRSF1 as an important prognostic factor, MM patients with various genetic alterations and disease statuses should be enrolled in the future study. This evidence concerns the gene SRSF1 and Miyoshi myopathy.